[The epigenome. Target for innovative therapies in head and neck carcinoma]

A Leipold1, J Hess, K Zaoui

  • 1Sektion Experimentelle und Translationale Kopf-Hals-Onkologie, Hals-Nasen-Ohrenklinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland

HNO
|October 23, 2015
PubMed
Abstract

Insights

Epigenetic aberrations drive head and neck squamous cell carcinoma (HNSCC) development and progression. Understanding these epigenetic changes offers new diagnostic biomarkers and therapeutic targets for HNSCC.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Context:

  • Head and neck squamous cell carcinoma (HNSCC) pathogenesis involves complex genetic and epigenetic alterations.
  • Epigenomic regulation, primarily through DNA methylation and histone modifications, influences cellular plasticity in health and disease.

Purpose:

  • To explore the role of epigenetic modifications in HNSCC initiation and progression.
  • To highlight the potential of epigenetic alterations as diagnostic and prognostic biomarkers.
  • To identify epigenetic regulators as targets for novel HNSCC therapies.

Summary:

  • Epigenetic alterations are crucial in the multistage process of HNSCC development.
  • These modifications impact tumor stem cells and contribute to treatment resistance.
  • The stability of epigenetic marks makes them valuable biomarkers, while their reversibility offers therapeutic opportunities.

Impact:

  • Advances understanding of HNSCC pathogenesis.
  • Identifies potential biomarkers for early detection and prognosis.
  • Paves the way for developing targeted epigenetic therapies for HNSCC.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.2K